PTEN and prostate carcinoma: For this purpose, Islam et al. developed self-assembling polymer poly(lactic-co-glycolic acid PLGA)-lipid (GO-C14) hybrid nanoparticles coated with a polyethylene glycol (PEG) shell for the effective delivery of therapeutic PTEN mRNA into PTEN-null prostate cancer cells.